Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
GE Vernova heads into its October 28 earnings date with the stock off 2.4% on the week to $1,004, while analysts debate how much of the bull case is already priced in.
The most active storyline this week has been on the Street, where target cuts are outnumbering upgrades even as bullish ratings hold firm. JP Morgan trimmed its target to $1,150 from $1,330 on October 9, keeping an Overweight rating but acknowledging the stock's valuation has moved ahead of near-term fundamentals. Susquehanna followed on October 14 with a smaller cut to $1,270 from $1,300, also maintaining a Positive stance. Against that, Guggenheim reiterated its Buy and $1,450 target on October 13, the most optimistic on the recent list. The consensus mean target of $1,224 still implies around 22% upside from current levels, and no one in the recent activity has downgraded the rating outright. The exception worth flagging is GLJ Research, which initiated in September with a Sell and a $470 target, a figure so far below the pack that it reflects a fundamentally different view of the business rather than a calibration difference. Valuation multiples have drifted higher over the past month: the price-to-earnings ratio has expanded by roughly 4 points to 43.5x, and price-to-book has climbed about 1.8 points to 15x, giving bears a concrete number to point at. The bull case rests on Power and Electrification franchise strength, with full-year revenue guidance raised to $45.5-46.5bn and free cash flow guidance to $11.5-12.5bn. Bears point to decelerating turbine contract additions, wind still burning through roughly $400m of EBITDA losses this year, and supply chain bottlenecks that could cap execution.
The lending market remains emphatically disinterested in the short thesis. Availability is running at 4,513%, meaning there are roughly 45 shares available to borrow for every one already shorted. That is a loosening from where availability was a month ago, when it sat closer to 2,200 to 2,500%. Short interest has fallen 14% over the past week to 2.6% of the free float, continuing a steady decline from the 8.4-8.8m share range seen in mid-September. Cost to borrow has nudged up to 0.43% from 0.24% earlier in the week, but that is still negligibly low and consistent with a borrowing market that places no real friction on new short positions. The ORTEX short score has eased to 33.8 from 36 at the start of October, reinforcing the picture of bears stepping back rather than building. Note that the previous note from October 7 cited shorts retreating and that trend has continued: SI is down a further 14% week-on-week from the level described then.
Options positioning has grown slightly less defensive than its recent norm. The put/call ratio is at 1.38, modestly below its 20-day average of 1.40, and around one standard deviation beneath that average. The 52-week range on the PCR runs from 0.96 to 1.50, so the current reading is closer to the midpoint than to either extreme. That is a mild shift toward calls relative to the past month, consistent with a market that is positioning for the earnings event but not aggressively hedging downside.
Institutional ownership is broadly stable. BlackRock added just over 1m shares to reach 8.2% of shares outstanding as of September 30, making it the largest declared holder. Capital Research added roughly 506,000 shares to a 2.5% stake over the same period. On the activist register, The Vanguard Group filed an amended 13G in March showing a stake of 0% after previously disclosing 8.69%, while Vanguard Capital Management filed a fresh 13G in April at 7.47%. These appear to reflect a restructuring of how Vanguard entities report rather than a genuine exit and re-entry, but as with all 13D/G disclosures, positions are as last declared and can change without a further filing once below the 5% threshold. No 13D activist is on the register.
The sole reference point for how the stock behaves on results day is the July 22 print, which produced a 4.4% decline on the day and a 16.5% drawdown over the following five days. With the stock trading at a richer valuation now than it did heading into that quarter, and with JP Morgan and Susquehanna having already trimmed their targets this week, the setup heading into October 28 is one where the magnitude of the reaction will depend heavily on whether turbine contract additions and Wind losses land inside or outside the range the market has already absorbed.
See the live data behind this article on ORTEX.
Open GEV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
